Privia Health Group, Inc. (PRVA) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 634.44M USD | Liabilities, Current |
| Cash and equivalents | 412.20M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 574.16M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $634.44M | $412.20M | (m) | $574.16M | (m) | (m) |
| 2026-03-31 | (m) | $601.30M | $419.52M | (m) | $513.68M | (m) | (m) |
| 2025-12-31 | (m) | $568.52M | $479.69M | (m) | $400.90M | (m) | (m) |
| 2025-09-30 | (m) | $582.91M | $441.35M | (m) | $499.04M | (m) | (m) |
| 2025-06-30 | (m) | $534.85M | $390.13M | (m) | $443.99M | (m) | (m) |
| 2025-03-31 | (m) | $470.81M | $469.33M | (m) | $388.73M | (m) | (m) |
| 2024-12-31 | (m) | $449.15M | $491.15M | (m) | $316.18M | (m) | (m) |
| 2024-09-30 | (m) | $479.47M | $422.00M | (m) | $408.96M | (m) | (m) |
| 2024-06-30 | (m) | $429.59M | $387.35M | (m) | $370.06M | (m) | (m) |
| 2024-03-31 | (m) | $403.80M | $351.14M | (m) | $346.09M | (m) | (m) |
| 2023-12-31 | (m) | $386.95M | $389.51M | (m) | $290.77M | (m) | (m) |
| 2023-09-30 | (m) | $394.19M | $330.39M | (m) | $350.11M | (m) | (m) |
| 2023-06-30 | (m) | $358.44M | $317.94M | (m) | $319.84M | (m) | (m) |
| 2023-03-31 | (m) | $309.69M | $311.23M | (m) | $260.88M | (m) | (m) |
| 2022-12-31 | (m) | $264.27M | $347.99M | (m) | $189.60M | (m) | (m) |
| 2022-09-30 | (m) | $304.53M | $316.90M | (m) | $246.35M | (m) | (m) |
| 2022-06-30 | (m) | $265.14M | $292.19M | (m) | $213.89M | (m) | (m) |
| 2022-03-31 | (m) | $220.35M | $315.93M | (m) | $166.24M | (m) | (m) |
| 2021-12-31 | (m) | $190.46M | $320.58M | (m) | $117.40M | (m) | (m) |
| 2021-09-30 | (m) | $187.24M | $362.11M | (m) | $98.38M | (m) | (m) |
| 2021-06-30 | (m) | $167.32M | $299.75M | (m) | $126.87M | (m) | (m) |
| 2021-03-31 | (m) | $157.52M | $81.94M | (m) | $116.72M | (m) | (m) |
| 2020-12-31 | (m) | $146.94M | $84.63M | (m) | $99.12M | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |